Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02660424 · ClinicalTrials.gov registry record · Phase 2
A Study of the Efficacy and Safety of VX-150 in Subjects With Osteoarthritis of the Knee
A Phase 2 study of Osteoarthritis, sponsored by Vertex Pharmaceuticals Incorporated.
- Completed
- Registry status
- Phase 2
- Development phase
- 124
- Enrollment target
- 12
- Study locations
NCT02660424 is a Phase 2 study of Osteoarthritis that has completed, run by Vertex Pharmaceuticals Incorporated. The registered enrollment target is 124 participants, below the 817-participant average among 135 other Osteoarthritis trials with a reported enrollment target (85% lower). The trial reports 12 study locations across 12 states.
The verdict
NCT02660424, a Phase 2 study of Osteoarthritis, has completed, sponsored by Vertex Pharmaceuticals Incorporated.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 124 participants
- Enrollment target
- 12
- Study locations
Study Summary
The Primary objective of this study is to evaluate the efficacy of VX-150 in the treatment of osteoarthritis pain
Conditions Studied
Interventions
- DRUG Placebo
- DRUG VX-150
Study Locations (12)
California
- - San Diego
Florida
- - West Palm Beach
Georgia
- - Marietta
Indiana
- - Valparaiso
Kansas
- - Wichita
Michigan
- - Bay City
Nevada
- - Las Vegas
New York
- - Hartsdale
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 124 participants |
| Start Date | 2015-12 |
| Est. Completion | 2016-09 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02660424
The ClinicalTrials.gov registry entry for NCT02660424 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 124 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 817-participant average among 135 other Osteoarthritis trials with a reported enrollment target (85% lower). The listed sponsor is Vertex Pharmaceuticals Incorporated, which has 191 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Osteoarthritis appearing as the primary indexed condition, and to 2 interventions - of which Placebo is the first listed.
NCT02660424 reports 12 study locations spanning 12 distinct geographic areas - top geographies include California, Florida, Georgia.
Frequently Asked Questions
What is clinical trial NCT02660424 about?
NCT02660424 is a clinical study titled "A Study of the Efficacy and Safety of VX-150 in Subjects With Osteoarthritis of the Knee". The Primary objective of this study is to evaluate the efficacy of VX-150 in the treatment of osteoarthritis pain
What is the current status of trial NCT02660424?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 124 participants. The study started on 2015-12. Estimated completion is 2016-09.
What conditions does trial NCT02660424 study?
This clinical trial studies the following conditions: Osteoarthritis.
What interventions are being tested in trial NCT02660424?
The interventions under investigation include: Placebo (DRUG), VX-150 (DRUG).
Who is sponsoring clinical trial NCT02660424?
This trial is sponsored by Vertex Pharmaceuticals Incorporated, which has 191 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02660424 being conducted?
This trial has 12 study locations across California, Florida, Georgia, Indiana, Kansas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Osteoarthritis
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Safety & Effectiveness of Autologous Regenerative Cell Therapy on Pain & Inflammation of Osteoarthritis of the Knee
RECRUITING · Phase 2
-
Safety & Effectiveness of Autologous Regenerative Cell Therapy on Pain & Inflammation of Osteoarthritis of the Shoulder
RECRUITING · Phase 2
-
Safety & Effectiveness of Autologous Regenerative Cell Therapy on Pain & Inflammation of Osteoarthritis of the Hip
RECRUITING · Phase 2
-
Platelet Rich Plasma Injections In Young And Old Human Subjects
RECRUITING · Phase 2
-
A Mobile Intervention to Reduce Pain and Improve Health-III
RECRUITING · Phase 2
-
An Study to Evaluate Safety and Tolerability of OA-SYS in Subjects With Moderate to Severe Osteoarthritis of the Knee Joint
RECRUITING · Phase 2
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.